Proactive Investors - Run By Investors For Investors

Mediclinic gets a shot in the arm from reported Adu Dhabi regulatory change

Mediclinic noted reported comments by the crown prince of Abu Dhabi ordering the waiving of a 20% co-payment for holders of a Thiqa medical insurance card
Hospital
In early morning trading, Mediclinic was by far and away the top FTSE 100 gainer, leaping over 18%, or 136p higher to 867p

Mediclinic International Plc (LON:MDC) got a shot in the arm today, with its shares soaring on reports of  a positive regulatory change in Abu Dhabi, an area which has weighed on the group.

In early morning trading, Mediclinic  was by far and away the top FTSE 100 gainer, leaping over 18%, or 136p higher to 867p.

In a statement, the Middle East-focused private healthcare group noted reported comments by the crown prince of Abu Dhabi ordering the waiving of a 20% co-payment for holders of a Thiqa medical insurance card when receiving treatment at private healthcare facilities in Abu Dhabi.

READ: Mediclinic's full year trading in line with expectations except Abu Dhabi

CLICK HERE: For a daily round-up of all the Proactive news

The Health Authority of Abu Dhabi (HAAD) had  introduced the 20% co-payment for Thiqa patients, those covered by health insurance for UAE Nationals or others of similar status in the country on 1 July 2016.

Mediclinic said it is awaiting precise details on these regulatory changes from  HAAD and will continue to monitor the regulatory environment and the effect of these changes on its Middle East business.

Mediclinic bought a group of hospitals in Abu Dhabi in 2015

In an update earlier this month, Mediclinic said trading for the 2017 financial year was in line with expectations, apart from its Abu Dhabi business.

It added that the Abu Dhabi business underperformed due to regulatory changes and certain business and operational challenges.

Mediclinic bought a group of hospitals in Abu Dhabi in 2015 through a reverse takeover of Al Noor Group Hospitals.

The group operates six hospitals and 34 clinics in the UAE, and its Mediclinic Middle East business contributed 16% of revenue for its financial year ended in March.

CLICK HERE: For a daily round-up of all the Proactive news

View full MDC profile View Profile

Mediclinic International Plc Timeline

Related Articles

test tubes
May 07 2019
Here we take a closer look at Arix Biosciences PLC (LON:ARIX), a listed venture capital company that doesn’t appear to be receiving the recognition it deserves
Social media use
April 18 2019
Social first has allowed sites like UNILAD to amass a huge audience with very little capital injection, but what is social first publishing and how is it changing the nature of content and advertising?
An instrument made by Pressure BioSciences
June 26 2019
The company’s high-pressure technologies can help drug makers produce protein-based therapeutics, a market expected to touch $240 billion by 2023

© Proactive Investors 2019

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use